Mental health and mood GLP-1 medications have been under regulatory review for possible links to suicidal thoughts and mood changes
Now that Foundayo is on the market, he's planning to chat to his doctor about possibly getting back on the medication
The guideline is designed as a living document that will be updated as new real-world and long-term evidence emerges. In effect, the WHO is saying: the benefits are real, but we must continue to study safety, durability, and what happens when treatment stops. Where there is evidence for GLP-1 efficacy and safety, the WHO notes that existing studies are at serious risk of bias and are of either low or very low quality
Niacinamide was shown to reduce melanosome transfer, associated with a brighter, more even-looking tone
These medications work by inhibiting glucose reabsorption in the renal proximal tubule, promoting urinary glucose excretion
Scand J Pain